About Mcronus Lifescience Private Limited
Data last updated:
Mcronus Lifescience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC301056. Its GSTIN is 27AALCM4022A1ZX (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Maheshwari Swami Amreshwar and Nirmala Padasalage.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No. 442 Bldg No.1A Gen 2/1/C Turbhe Navi Mumbai, Maharashtra, India – 400701.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.1 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹25.54 Lakh (net margin 2.8%) and EBITDA of ₹42.1 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 27% over five years.
The company has about 55 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mcronus.com.
Company details
Contact details
Mcronus Lifescience Private Limited's registered office is in Mumbai, Maharashtra. Its website is mcronus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala No. 442 Bldg No.1A Gen 2/1/C Turbhe Navi Mumbai, Maharashtra, India – 400701
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mcronus Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mcronus Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mcronus Lifescience Private Limited, buy the company report.
Financials of Mcronus Lifescience Private Limited
FY 2025 filings availableMcronus Lifescience Private Limited reported revenue of ₹9.1 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 12% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mcronus Lifescience Private Limited, buy the company report.
Board of directors of Mcronus Lifescience Private Limited
Mcronus Lifescience has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maheshwari Swami Amreshwar | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
| Nirmala Padasalage | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
| Mahesh Virayya Padsalge Also directs: Henox Medical Systems Private Limited | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
| Virappa Gurulingyya Padsalge | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Mcronus Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kidney Care Fluids Private Limited | ₹9.12 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Dermocare Laboratories(Gujarat) Private Limited | ₹9.12 Cr (FY 2017) | -2.0% | Changodar, Gujarat, India | |||
| R.S. Fragrances International Private Limited | ₹9.12 Cr (FY 2025) | 36.0% | Kolkata, West Bengal, India | |||
| Vallabh Bio Science Private Limited | ₹9.12 Cr (FY 2025) | 73.0% | Rohtalav, Gujarat, India | |||
| Hanumant Biosciences Private Limited | ₹9.11 Cr (FY 2024) | 200.0% | Surat, Gujarat, India | |||
| Mcronus Lifescience Private Limitedthis company | ₹9.1 Cr (FY 2025) | ₹25.54 Lakh | 2.8% | 12.0% | 55 | Mumbai, Maharashtra, India |
| Malve Chemicals (India) Private Limited | ₹9.1 Cr (FY 2024) | 11.0% | Badlapur, Maharashtra, India | |||
| Sudhir Life Sciences Private Limited | ₹9.1 Cr (FY 2025) | 12.0% | Jabalpur, Madhya Pradesh, India | |||
| Manara Healthcare Private Limited | ₹9.1 Cr (FY 2025) | 48.0% | Aroor, Kerala, India | |||
| Parth Laboratories Pvt Ltd | ₹9.09 Cr (FY 2025) | -4.0% | Rajkot, Gujarat, India | |||
| Ujwal Pharma Pvt Ltd | ₹9.09 Cr (FY 2024) | -12.0% | Thane, Maharashtra, India |
To see the full peer comparison of Mcronus Lifescience Private Limited, buy the company report.
Auditor
Mcronus Lifescience Private Limited is audited by PATIL MAHTRE & POL LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PATIL MAHTRE & POL LLP | FY 2023 | 136420W |
Shareholding
The shareholding of Mcronus Lifescience Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mcronus Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mcronus Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mcronus Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mcronus Lifescience Private Limited has a workforce of 55 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
GST
Mcronus Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCM4022A1ZX | Maharashtra | Active | 12 Apr 2018 |
To see the full GST registrations and return filing status of Mcronus Lifescience Private Limited, buy the company report.
Recent activity
Mcronus Lifescience Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Mahesh Virayya Padsalge was appointed as Director on 23 Oct 2017.
Frequently asked questions
Mcronus Lifescience is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 October 2017 (9+ years old) and is registered under CIN U24304MH2017PTC301056.
Mcronus Lifescience has 4 current directors:
- Maheshwari Swami Amreshwar - Director
- Nirmala Padasalage - Director
- Mahesh Virayya Padsalge - Director
- Virappa Gurulingyya Padsalge - Director
The latest financial statements of Mcronus Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Mcronus Lifescience is 27AALCM4022A1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Mcronus Lifescience is U24304MH2017PTC301056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mcronus Lifescience was incorporated on 23 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mcronus Lifescience by revenue are Kidney Care Fluids Private Limited, Dermocare Laboratories(Gujarat) Private Limited, R.S. Fragrances International Private Limited, Vallabh Bio Science Private Limited, Hanumant Biosciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mahesh Virayya Padsalge was appointed as Director on 23 Oct 2017. Maheshwari Swami Amreshwar was appointed as Director on 23 Oct 2017. Nirmala Padasalage was appointed as Director on 23 Oct 2017. Mcronus Lifescience has 4 board changes on record in total.
Mcronus Lifescience can be reached through the website mcronus.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mcronus Lifescience is at Gala No. 442 Bldg No.1A Gen 21C Turbhe Navi Mumbai, Maharashtra, India – 400701.
Mcronus Lifescience operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
